Sequence and analysis of a whole genome from Kuwaiti population subgroup of Persian ancestry by unknown
Thareja et al. BMC Genomics  (2015) 16:92 
DOI 10.1186/s12864-015-1233-xRESEARCH ARTICLE Open AccessSequence and analysis of a whole genome from
Kuwaiti population subgroup of Persian ancestry
Gaurav Thareja†, Sumi Elsa John†, Prashantha Hebbar, Kazem Behbehani, Thangavel Alphonse Thanaraj*
and Osama Alsmadi*Abstract
Background: The 1000 Genome project paved the way for sequencing diverse human populations. New genome
projects are being established to sequence underrepresented populations helping in understanding human genetic
diversity. The Kuwait Genome Project an initiative to sequence individual genomes from the three subgroups of
Kuwaiti population namely, Saudi Arabian tribe; “tent-dwelling” Bedouin; and Persian, attributing their ancestry to
different regions in Arabian Peninsula and to modern-day Iran (West Asia). These subgroups were in line with
settlement history and are confirmed by genetic studies. In this work, we report whole genome sequence of a
Kuwaiti native from Persian subgroup at >37X coverage.
Results: We document 3,573,824 SNPs, 404,090 insertions/deletions, and 11,138 structural variations. Out of the
reported SNPs and indels, 85,939 are novel. We identify 295 ‘loss-of-function’ and 2,314 ’deleterious’ coding variants,
some of which carry homozygous genotypes in the sequenced genome; the associated phenotypes include
pharmacogenomic traits such as greater triglyceride lowering ability with fenofibrate treatment, and requirement of
high warfarin dosage to elicit anticoagulation response. 6,328 non-coding SNPs associate with 811 phenotype traits:
in congruence with medical history of the participant for Type 2 diabetes and β-Thalassemia, and of participant’s
family for migraine, 72 (of 159 known) Type 2 diabetes, 3 (of 4) β-Thalassemia, and 76 (of 169) migraine variants are
seen in the genome. Intergenome comparisons based on shared disease-causing variants, positions the sequenced
genome between Asian and European genomes in congruence with geographical location of the region. On
comparison, bead arrays perform better than sequencing platforms in correctly calling genotypes in low-coverage
sequenced genome regions however in the event of novel SNP or indel near genotype calling position can lead to
false calls using bead arrays.
Conclusions: We report, for the first time, reference genome resource for the population of Persian ancestry. The
resource provides a starting point for designing large-scale genetic studies in Peninsula including Kuwait, and
Persian population. Such efforts on populations under-represented in global genome variation surveys help
augment current knowledge on human genome diversity.
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Arabian Peninsula, situated at the nexus of Africa,
Europe and Asia, has been implicated in early human
migration route out of Africa and in early inter-
continental trade routes [1-3]. The State of Kuwait is
situated at northwestern tip of Persian Gulf and is bor-
dered by Iraq and Saudi Arabia. Kuwaiti population is* Correspondence: alphonse.thangavel@dasmaninstitute.org; osama.alsmadi@
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unless otherwise stated.composed of early settlers from different regions in and
around Arabian Peninsula namely Persia, Saudi Arabia
and the deserts on the fringes of the Peninsula. Genetic
features characterize Kuwaiti population into these three
migratory subgroups [4-6].
The Persian subgroup is composed of people of West
Asian (particularly Iranian) descent [7]. Iran, centrally
located in the Asian continent, has served for centuries
as gateway for movement of human population across
diverse spheres of Asia and Europe. Iran is home to one
of the major ancient civilizations and has rich cultural. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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diverse ethnic and linguistic groups namely Arabs,
Armenians, Assyrians, Azeris, Baluchis, Gilaks, Mazandarani,
Kurds, Lurs, Persian, Turkmen and Zoroastrians. Y-
chromosome haplogroup studies also placed Iran at the
nexus of tri-continental human migration and as a con-
stant recipient of gene flow from the three continents
[9,10]. The Persian subgroup of Kuwaiti population mi-
grated into Kuwait from southwestern Iran and settled
much before the establishment of modern-day Kuwait,
the first group arriving around the second half of eight-
eenth century [7].
The 1000 Genomes Project [11] has illustrated that as
high as 53% of rare variants (at minor allele frequency,
MAF ≤ 0.5%) are observed only in individual popula-
tions, and that 17% of low-frequency variants (at MAF
of 0.5% to 5%) are observed in single ancestry groups.
Thus, it is essential to sequence diverse global populations,
such as those that are underrepresented (e.g. Arabian
Peninsula) in global genome-wide surveys, to enlarge our
knowledge on human genome diversity.
Kuwait Genome Project (KGP) is an initiative to se-
quence individual genomes from three genetically dis-
tinct subgroups of Kuwaiti population at high coverage.
In this paper, we report whole genome sequence of an
individual from the Persian subgroup of Kuwaiti popula-
tion (KWP1) at >37X coverage. We catalog a total of
3,573,824 single nucleotide polymorphisms (SNPs),
404,090 short insertions/deletions (indels) of length ≤
50 bp, and 11,138 structural variations. The identified
variants include deleterious and loss-of-function coding
variants, as well as critical non-coding variants that are
associated with phenotype traits. We illustrate how the
medical history of the sequenced individual (Type 2 dia-
betes and β-Thalassemia) and of the family members
(migraine) is reflected in the identified genome variants.
The reported genome sequence, which can be used as
ancestry specific genome for discovering additional vari-
ants [12], and genome variants add to the human var-
iome diversity and may serve as terminus a quo for
larger sequencing projects on this population group of
Persian origin.
Results
Participant information and alignment statistics
A male participant aged 70 years, with self-reported his-
tory of Type 2 diabetes and β-Thalassemia (Minor) other-
wise leading an active lifestyle was randomly selected from
the Persian subgroup (Kuwait P as reported in our previ-
ous study [6]) of Kuwaiti population (Additional file 1:
Figure S1). The participant’s surname lineage traces back
its ancestry to a region in southern Iran and thus is in ac-
cordance with genetic clustering. The participant’s family
is settled in Kuwait for at least 5 generations. Participantwas further seen clustered with exomes of West Asian
origin from the State of Qatar [13] (Additional file 2:
Figure S2). The participant did not report any history of
cardiovascular disorders or other major ailments.
A total of 1,111,992,216 (QC-passed) reads of 101 bps
in length were generated covering human genome at
37.44X. Overall, 1,058,855,102 (95.22%) of the reads
were mapped to reference human genome properly -
i.e. the output of the Sequence Alignment/Map (SAM)
tool for these mapped reads indicate that the reads
aligned properly according to the aligner. Out of
1,058,855,102 mapped reads, 98.57% reads were mapped
in proper pairs, 10,835,756 reads were singletons and
1,284,321 reads had their mates mapped to different
chromosomes (mapQ > 5).
Y-chromosome and mitochondrial haplogroups of the
participant
The participant belongs to L1c [L-M357, L3] Y-chromo-
some haplogroup and HV14 [HV1a2] mitochondrial hap-
logroup. All three subgroups of L (L1a (M76), L1b
(M317), and L1c (M357)) are present in Iran and Pakistan
[14]. L1a is the most common subgroup found in India
and L1b (M317) is rarest of the three in south Asia. L1c
haplogroup is seen, though in low frequencies (2-4%), in
the northern part of the Middle East (Iran, Turkey,
Armenia, Kurdistan, Lebanon). It has been observed in
1.6% of the 938 male participants recruited to study
Y-chromosome variation in modern Iran [10]. This
haplogroup is also observed in Pashtun tribes from
Afghanistan [15]. The HV mitochondrial haplogroup has
a west Eurasian origin and is found throughout West
Asia and Southeastern Europe, including Iran, Anatolia
(present-day Turkey), the Caucasus Mountains of southern
Russia and the Republic of Georgia [16]. Thus, the identi-
fied Y-chromosome and mitochondrial haplogroups are
consistent with the Persian ancestry of the participant.
Observed single nucleotide polymorphisms (SNPs) and
indels
A total of 3,573,824 SNPs and 404,090 indels (of
length ≤50 bp) were identified through comparing
KWP1 genome with human reference genome (hg19)
[17]. The number of reported SNPs is in concordance
with mean of 3,596,151 SNPs as seen in sequencing
100 Malay Genomes using similar technology and at
similar coverage [18].
Of these variants, 58,186 (1.63%) SNPs and 27,753
(6.87%) indels are ‘novel’. This set of novel variants in-
cludes 1,547 SNPs and 4,577 indels having alleles not re-
ported in dbSNP 138 [19]. The size distribution of the
novel indels is similar to that of the known indels
(Figure 1). The genome-wide Transition/Transversion
















Figure 1 Size distribution for indels in coding and non-coding regions.
Thareja et al. BMC Genomics  (2015) 16:92 Page 3 of 14(Additional file 3: Figure S3). The observed value in the
case of novel SNPs at 1.96 is lower than the expected
range of ~2.0-2.1; this can be due to one or a combin-
ation of the following reasons: possibility of residual false
positives, possibility of a relative deficit in transitions
due to sequencing context bias, or because of the appar-
ently higher transition ratio often associated with low
frequency variants [20].
Annotation of SNPs and indels based on genomic
locations
The identified SNPs and indels were classified into thir-
teen broad classes based on their genomic locations
(Additional file 4: Table S1). In addition, the variants
from coding regions were classified into thirteen classes
based on their locations in exonic regions and their ef-
fects on protein sequences (Table 1). Most of the known
and novel variants lie in intergenic regions.
A set of 278 known exonic variants were annotated as
LOF (Loss-of-Function) variants. This includes 147
SNPs and 131 indels which result in premature stops,
splice-site disruptions and frame shifts. The number of
identified LOF variants is consistent with previous re-
ported average of 250 to 300 in 1000 Genomes Project
[21]. Of these 278 exonic LOF variants, 130 variants
(61 SNPs (Additional file 5: Table S2) and 69 indels
(Additional file 6: Table S3)) are homozygous alternate
leading to complete loss of function. Interestingly, none
of the identified 17 novel exonic LOF variants (6 SNPsand 11 indels) are homozygous alternate. Previous stud-
ies have also shown at least 30 LOFs in homozygous
state in a healthy individual [22]. A higher number of
homozygous LOFs could be due to high inbreeding coef-
ficient of 0.0196, as estimated in our previous study [6],
and tradition of consanguineous marriages in the family
of participant.
Allele frequency analysis, using data from 1000 Ge-
nomes Project, of 58 (out of the above-mentioned 61)
homozygous exonic LOF SNPs showed that 13 of these
SNPs are rare variants (with MAF ≤ 0.05) (Additional file
7: Figure S4); thus it can be safely inferred that these
LOF mutations are genuine and are not sequencing arti-
facts. Furthermore, out of 61 LOF homozygous SNPs, 17
are annotated as expression quantitative trait loci
(eQTLs) in various populations [23] (Additional file 8:
Table S4). These 130 homozygous LOF variants lie in
125 genes. Clustering of these genes based on gene func-
tion using DAVID [24] did not result in any significant
cluster classification.
We further report 2,123 known (Additional file 9: Table
S5) and 91 novel SNPs (Additional file 10: Table S6) that
are predicted to be “deleterious”; these deleterious SNPs
are distributed across 1,173 genes. 6.6% of the novel dele-
terious SNPs and 28% of the known deleterious SNPs are
homozygous, Of the known 2,123 deleterious SNPs, 9 are
common with the LOF data set. There is no enrichment
of disease classes, but analysis using DAVID tool showed
an enrichment of olfactory receptor activity with Benjamin
Table 1 Classification of the identified coding SNPs based










Init Codon 16 0 3 1
Non SNV 9197 193
Splicing 68 2 44
Stopgain 63 4 2 1
Stoploss 10 0
Synonymous 10405 108
Unknown 440 1 70 1
Del - - 84 3
FrameShift Del - - 42 8
FrameShift Ins - - 32 2
Ins - - 70 5
$Legends to the class types.
Splicing, Variant affects a nucleotide that is in a splicing region of a
coding transcript.
Init Codon, Variant changes the start codon.
Frameshift Ins, An insertion that causes a shift in the codon reading frame.
Frameshift Del, A deletion that causes a shift in the codon reading frame.
Frameshift Sub, A substitution that causes a shift in the codon reading frame.
Stopgain, Variant causes a stop codon to be created at the variant site.
Stoploss, Variant changes a stop codon to something else.
Ins, An insertion that does not cause a frameshift.
Del, A deletion that does not cause a frameshift.
Sub, A substitution that does not cause a frameshift.
Nonsyn SNV, A single nucleotide variant that changes the amino acid
produced by a codon.
Synonymous, A variant affecting 1 or more nucleotides that does not change
the amino acid sequence.
Unknown, A problem was found with the protein coding sequence, See
Invalid Transcripts.
SNP & Variation Suite v8.1 (SVS) [Bozeman, MT: Golden Helix, Inc] was used
for classifications.
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factory receptor activity was observed in analysis of whole
genome sequence of Indian individual [25].
Associating identified variants with phenotype traits
A major challenge in delineating functional aspects from
personal genomes lies in relating the variants with bio-
logical phenotypes such as pharmacogenomic traits, dis-
ease risks and other common phenotypic traits (e.g. hair
and eye color). Of the identified homozygous LOF vari-
ants, rs5758511 [22:g.42336172G > A leading to stop
codon gain] (CENPM gene [MIM: *610152] is seen asso-
ciated with the biological phenotype of decrease in birth
weight [26]. As birth weight is often associated with
metabolic syndromes [27], it is important to look for
these signals relatively early. Further, the CENPM gene
has been shown to be associated with benzene haemato-
toxicity [28] and body weight [29].
We could further delineate genotype-disease associa-
tions in the case of 28 SNPs from the set of ‘known’
deleterious SNPs (Table 2). The participant is a carrierof homozygous genotypes at three of the following
deleterious SNPs; rs2304256 [19:g.10475652C > A]
[Val362Phe] (TYK2 gene [MIM:*176941]), rs1799990
[20:g.4680251A > G] [Met129Val] (PRNP gene [MIM:
*176640]), rs676210 [2:g.21231524G > A] [Pro2739Leu]
(APOB gene [MIM:+107730] – these markers are associ-
ated with susceptibility to Type 1 diabetes [30], long-
term memory [31] and triglycerides level [32-34], The
observed homozygous genotype of (AA) at rs2304256
provides protection from Type 1 diabetes [30]. As
regards to the homozygous genotype of GG seen at
rs1799990 in the sequenced genome, it has been re-
ported that twenty-four hours after a word list-learning
task, carriers of either the (AA) or (AG) genotypes
recalled 17% more information than (GG) genotype car-
riers, but short-term memory was unaffected [31].
rs676210 has been associated with triglyceride (TG) re-
sponse to fenofibrate treatment for hypertriglyceridemia
[35]; participants having the homozygous AA genotype
(as is the case with the sequenced genome in this study)
at rs676210 have greater triglyceride lowering ability
than those with the CC genotype in response to fenofi-
brate treatment. Though risk alleles are seen at these
variants, the manifestation is not seen in the participant.
For example, participant medication history does not
state use of fenofibrate and his triglyceride levels are re-
ported to be normal at 0.82 mmol/L. In future, if these
phenotypes manifests in the participant, these findings
can aid physicians in treating the participant.
The remaining deleterious SNPs that are heterozygous,
include rs2108622 [19:g.15990431C > T] [Val433Met]
(CYP4F2 gene [MIM: *604426]) that is associated with
Warfarin drug response and altered Vitamin K (VK1)
metabolism. It has been shown that compared to indi-
viduals with the homozygous CYP4F2 genotype (CC) at
rs2108622, carriers of the heterozygous CT (and homo-
zygous TT) genotypes require higher warfarin doses to
elicit anticoagulation response [36-39]. An earlier study
in Kuwait has also reported poor quality of anticoagula-
tion with Warfarin [40]. Other phenotypes such as mul-
tiple sclerosis and obesity are also seen in this list of
deleterious SNPs (Table 2).
From the remaining known non-coding SNPs, we
annotated 6,328 SNPs corresponding to 811 traits
(Additional file 11: Table S7). 2,457 (38.8%) of these
6,328 SNPs are homozygous. In congruence with the re-
ported history of Type 2 diabetes and β-Thalassemia
(Minor) by the participant, we find the presented gen-
ome to exhibit 72 out of 159 Type 2 diabetes and 3 out
of 4 β-Thalassemia variants as annotated in NHGRI
GWAS Catalog. We find that most of the observed 72
Type 2 diabetes SNPs have been discovered in popula-
tions of South and East Asian descent [41] (19 in South
Asian, 7 in South & East Asian (Study sample contains
Table 2 Genotype-phenotype associations in the case of 28 SNPs from the set of ‘known’ deleterious SNPs
SNP Mapped gene [MIM] Genotype Phenotype Pubmed ID
rs1801133 [1:g.11856378G > A] [Ala263Val] MTHFR [607093] het Homocysteine levels 23824729
rs676210 [2:g.21231524G > A] [Pro2739Leu] APOB [107730] hom triglyceride (TG) response to fenofibrate
treatment for hypertriglyceridemia; LDL
(oxidized), Lipid metabolism phenotypes
23247145
rs6756629 [2:g.44065090G > A] [Arg50Cys] ABCG5 [605459] het Cholesterol, total, LDL cholesterol 19060911
rs16891982 [2:g.21231524G > A] [Pro2739Leu] SLC45A2 [606202] het Skin pigmentation, Hair color, Eye color 17999355
rs2043112 [5:g.38955796G > A] [Ser837Phe] RICTOR [609022] het Obesity-related traits 23251661
rs30187 [5:g.96124330 T > C] [Lys528Arg] ERAP1 [606832] het Ankylosing spondylitis 21743469
rs33980500 [6:g.111913262C > T] [Asp10Asn] TRAF3IP2 [607043] het Psoriatic arthritis, Psoriasis 20953186
rs7076156 [10:g.64415184A > G] [Thr62Ala] ZNF365 [607818] het Crohn’s disease 22412388
rs5006884 [11:g.5373251C > T] [Leu172Phe] OR51B6 (Paralog of
OR51E1 MIM:* [611267]
het Fetal hemoglobin levels 20018918
rs11042023 [11:g.8662516 T > C] [His322Arg] TRIM66 [612000] het Obesity 23563607
rs2306029 [11:g.46893108 T > C] [Ser1554Gly] LRP4 [604270] het D-dimer levels 21502573
rs11230563 [11:g.60776209C > T] [Arg225Trp] CD6 [186720] het Inflammatory bowel disease 23128233
rs6591182 [11:g.65349756 T > G] [Val538Gly] EHBP1L1 het Non-alcoholic fatty liver disease histology
(lobular)
20708005
rs1042602 [11:g.88911696C > A] [Ser192Tyr] TYR [606933] het Skin pigmentation, Freckles 17999355
rs1126809 [11:g.89017961G > A] [Arg402Gln] TYR [606933] het Tanning,Sunburns 23548203
rs3213764 [12:g.14587301A > G] [Lys530Arg] ATF7IP [613644] het Prostate-specific antigen levels 23359319
rs4149056 [12:g.21331549 T > C] [Val174Ala] SLCO1B1 [604843] het Sex hormone-binding globulin levels, Bilirubin
levels, Response to statin therapy
22829776
rs883079 [12:g.114793240C > T] [3' UTR variant] TBX5 [601620] het Ventricular conduction 21076409
rs17730281 [15:g.53907948G > A] [Leu829Phe] WDR72 [613214] het Renal function-related traits (BUN) 22797727
rs12968116 [18:g.55322502C > T] [Arg952Gln] ATP8B1 [602397] het Liver enzyme levels (gamma-glutamyl transferase) 22001757
rs2304256 [19:g.10475652C > A] [Val362Phe] TYK2 [176941] hom Type 1 diabetes, Type 1 diabetes autoantibodies 21829393
rs2108622 [19:g.15990431C > T] [Val433Met] CYP4F2 [604426] het Acenocoumarol maintenance dosage, Vitamin E
levels, Metabolite levels, Warfarin maintenance
dose, Response to Vitamin E supplementation
19578179
rs8100241 [19:g.17392894G > A] [Ala20Thr] ANKLE1 het Breast cancer 22976474
rs2363956 [19:g.17394124 T > G] [Leu173Trp] ANKLE1 het Ovarian cancer 20852633
rs1434579 [19:g.44932972C > T] [Gly662Arg] ZNF229 [Paralog of
ZNF224 MIM:* [194555]
het Tuberculosis 20694014
rs2303759 [19:g.49869051 T > G] [Met34Arg] DKKL1 [605418] het Multiple sclerosis 21833088
rs1799990 [20:g.4680251A > G] [Met129Val] PRNP [176640] hom Long-term memory 19081515
rs738409 [22:g.44324727C > G] [Ile148Met] PNPLA3 [609567] het Liver enzyme levels (alanine transaminase),
Nonalcoholic fatty liver disease
22001757
Only in the case of these 28 (of the identified 2123 ‘known’ deleterious SNPs), the genotype-phenotype associations are known in NHGRI GWAS Catalog.
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and 18 in East Asian populations). As single locus has a
very modest effect on Type 2 Diabetes susceptibility and
all the reported loci seem to partly account for the herit-
ability of Type 2 Diabetes, it is difficult to say whether
one or few or all of these 72 SNPs influence the pheno-
type in the individual (Additional file 12: Table S8). The
three β-Thalassemia variants observed in the sequenced
genome are: rs766432 [2:g.60719970C > A] (seen as
homozygous in the studied genome; intronic, BCL11Agene [MIM: *606557]) [42], rs9376092 [6:g.135427144C >
A] (intergenic, HBS1L [MIM:*612450]-MYB [MIM:
*189990] genes) [43], and rs2071348 [11:g.5264146 T > G]
(intronic; HBBP1 gene) [44,45]. It has been reported that
these three loci are the best and common predictors of
the disease severity in β-Thalassemia [43]. Further, it is
noted that there is incidence of migraine in the family of
the participant; in conformity with this, we find the pre-
sented genome to exhibit 76 out of 169 migraine variants
annotated in GWAS Catalog.
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genomes from other continents
In order to assess the extent of variability that the
KWP1 genome exhibits, we performed inter-genome
comparisons with 10 representative genomes from four
continents and derived nearest-neighbor tree based on
genome-wide variant positions shared among genomes
(Figure 2A). KWP1 genome is seen located in the vicin-
ity of the five CEU genomes (Figure 2A). On rebuilding
the tree using only those shared SNPs, which are previ-
ously associated with human diseases cataloged in
OMIM database, we observe a change in the position of
KWP1 genome, now lying between the Asian and the
European genomes (Figure 2B) – this is in concordance
with geographical location of the origin of sample i.e. at
the nexus of Asian and European continents. This illus-
trates that disease profile of individual populations can
be different, irrespective of their overall shared origin
and that ethnicity acts as the dominant trend structuring
disease-associated SNP locations.
Annotation of the genome for structural variations
We identified 11,138 structural variations consisting of
7,645 deletions, 1,697 duplications, 585 insertions, 135
inversions and 1,076 translocations. Of the total 11,138
variations, as many as 10,283 (92.32%) are overlapping
with known structural variations in DGV (Database of
Genomic Variations, a curated catalog of human gen-
omic structural variations) [46]. Furthermore, we see
that 4279 (38.42%) of the reported structural variations
lie in previously annotated human repeat-rich regions
containing SINE (which include ALU), LINE and LTR
repeat elements (Table 3).Figure 2 Intergenome distances between the KWP1 genome and indi
based on variant positions shared between the KWP1 samples and individu
on variant positions associated with OMIM disease genes and are shared b
populations.Concordance in SNP Calls between the deep sequencing
experiment and genotyping experiment using Bead Chip
arrays
We observed an overall concordance of >99.8% for
homozygous and heterozygous SNPs (homo- or hetero-
zygosity is as per the genotype calls made in bead chip
data) between sequencing and bead chip data; 190 of
194,862 heterozygous SNPs and 148 of 117,317 homozy-
gous SNPs were seen wrongly called between two data
sets. In 28 instances of the 190 mismatch heterozygous
SNPs, they were called heterozygous in both data sets,
but their alleles do not match., Of these 28 SNPs, 22 are
annotated as multiallelic markers in dbSNP 138 and
variant calls made using sequencing data are subsets of
annotated alleles in dbSNP 138. Of the remaining 162
mismatch heterozygous SNPs, 62 lie in known copy
number variation regions as annotated in DGV and 3 lie
in known regions of genomic duplications as annotated
in Genomic Super Dups database [47]. On examining
the remaining 97 mismatch heterozygous SNPs, the read
depth in these regions ranges from 2–35 with a mean
depth of 14 (Additional file 13: Table S9). We looked at
a SNP rs6552934, having a read depth of 9 with 7 reads
supporting G allele and 2 reads supporting A allele, that
is called as GG in sequencing data (Figure 3A) but as
heterozygous AG in bead chip (Figure 3B); this instance
of sequencing call clearly indicates that genotype calls
using sequencing data can go wrong in regions of low
coverage.
Further, we examined the impact of novel SNPs and
indels in the vicinity of SNPs typed on bead chip. We
consider an exemplary SNP of rs3899654, which has a
novel heterozygous deletion of 2 bps upstream of theviduals from continental populations. (A) Nearest-neighbor tree
als from intercontinental populations. (B) Nearest-neighbor tree based
etween the KWP1 samples and individuals from intercontinental












Deletions 7645 7190 (94.05%) 2969 (38.84%)
Duplications 1697 1575 (92.81%) 212 (12.49%)
Insertions 585 514 (87.86%) 362 (61.88%)
Inversions 135 104 (77.04%) 26 (19.26%)
Translocations 1076 900 (83.64%) 710 (65.98%)
A detected structural variation is defined to be ‘known’ if at least 50% of the
detected variation (e.g. deletion) overlaps with a known variation.
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call (Figure 4A); however, the typed marker in bead chip
leads to inconsistent genotype call of CC (Figure 4B).
Further, we illustrate that there exist a considerable
number of novel SNPs and indels in KWP1 genome
around the typed common markers (Figure 5) which can
lead to inconsistent calls.
Genome view of the variants
Figure 6 provides a high-level view of the contents of
the draft genome sequence in terms of density of known
and novel variants (SNPs, short and long indels) ob-
served in KWP1 genome, density of duplications, and
the extent of chromosomal translocations. We have also
created a genome browser (see the section on Availabil-
ity of supporting data) for users to view an annotated
display of the identified variants and structural varia-
tions, in the context of sequence and annotation tracks
from other genome resources.
Discussion
This study, as part of Kuwait Genome Project (that plans
to derive reference genome sequences for the different
subgroups of Kuwaiti population), analyzes genome of a
Kuwaiti male participant with origin tracing back to
Persian tribes of Iran. This separate genetic subgroup of
Persian ancestry has also been reported in other states ofFigure 3 Illustration of discordance in SNP calls between the deep se
chip arrays. rs6552934 is considered as an example. (A) Sequencing dataArabian Peninsula, such as Qatar [49]. We report
around ~3.9 million genome variants, some of which
are novel.
Presence of Persians in Kuwait dates back to seven-
teenth and eighteenth centuries, but due to absence of
borders until the middle of twentieth century, there are
no historical records available [50]. Myron push-pull
theory [51] has often been used to explain Persian mi-
gration from southwest Iran to Kuwait. During the
period of late nineteenth century to the early twentieth
century, Southwest Iran was experiencing economic and
political difficulties. These difficulties acted as push
factors for Persian migration to places such as Dubai,
Sharjah, Abu Dhabi, Al-Doha, Basrah and Manamah. In
contrast, the pull factors typified by the political stability,
economic prosperity, low taxes and low crime rate
attracted Persians to State of Kuwait [52]. Presence of
the genetic subgroup of Persian ancestry in other states
of the Arabian Peninsula (as mentioned above) may sug-
gest that migrations among Gulf States might also have
happened; nautical trade along the Arabian Gulf might
have facilitated such intra-Peninsula migrations. In
modern-day Kuwait, up to 20 – 30% of the natives are of
Persian descent [53].
Large-scale sequencing initiatives are being proposed
[54] [http://rc.kfshrc.edu.sa/sgp/Index.asp] in the Peninsula
with the aim to provide comprehensive data on genome
variants instrumental in designing genome-wide bead ar-
rays for conducting large-scale genetic studies in popula-
tions of the region. Bead arrays are designed with two
assumptions: (1) the sequence in the sample is identical to
the probe sequence, except at the position to be genotyped,
and (2) there are only two possible alleles at the genotyped
position for which the array is designed [55]. We find ex-
amples to show that falsifying any of the above two condi-
tions can lead to wrong genotype calls from bead arrays.
Previous reports on utilization of genome-wide bead arrays
designed using reference human genome show that up to
34 % of published array-based GWAS studies for a varietyquencing experiment and genome-wide genotyping using bead
calls GG genotype. (B) Bead chip data calls AG genotype.
Figure 4 Impact of novel SNPs and indels in the vicinity of SNPs typed on bead chip on genotype calling. (A) Considered is an
exemplary SNP of rs3899654, which has a novel heterozygous deletion of 2 bps upstream of the variant in KGP1 genome, that has CT call.
(B) The typed marker in bead chip leads to inconsistent genotype call of CC.
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indels, or structural variants [56].
As sequencing experiments are gaining pace and large
studies are being designed to decipher genetic relation-
ships with common biological traits, unequal distribu-
tion of reads across genome regions can become a cause
of concern. Previous reports have shown that differences
in read depths across regions of genome and homozy-
gous SNP calls flatten when the read depth reaches a
threshold of 8, but heterozygous calls increase with in-
crease in read depth [57,58]. In this paper, we show that
a region of low read depth can cause false homozygous
call using sequencing data, but correct heterozygous call
was made using bead array. In a vicious circle of tech-
nology improvement, more large-scale sequencing stud-
ies on individual populations are needed to design more
robust bead arrays, however these large sequencingFigure 5 Count of novel SNPs and indels in KWP1 genome around typrojects can utilize the current bead arrays to improve
genotype calling in low coverage regions.
We demonstrate that the genome of the sequenced in-
dividual, who suffers from Type 2 diabetes, harbors as
many as 72 (out of the 159) variants previously associ-
ated with Type 2 diabetes. This observation has implica-
tions on global initiatives that strive to develop genome
panels to help in genetic susceptibility testing for Type 2
diabetes [59,60]. Several commercial companies offer
genome panels incorporating up to 38 variants designed
for different ethnicities [61]. Clinical utility evidence
provided by such panels that include differing number of
variants up to 38 has been found to be inadequate. In
our current study, we find that up to 72 markers relating
to Type 2 diabetes are seen in the sequenced genome.
We further demonstrate that the presented genome, of
the individual who has a medical history of β-Thalassemiaped common markers in bead chips.
Figure 6 Summary of analysis of genomes from Kuwait subgroup of Persian ancestry. Tracks (from outer to inner): Karyotype of Human
Genome; Density (in every window of 1 Mb) of ‘known’ SNPs (i.e. annotated in dbSNP 138); Density of ‘novel’ SNPs (i.e. not annotated in
dbSNP138); Density of ‘known’ indels; Density of ‘novel’ indels; Density of Long Deletions; Density of Long Insertions; Density of Inversions;
Density of Duplications; Links representing intra- and inter-chromosomal translocations. The image was generated using Circos [48].
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annotated in GWAS Catalog. Thalassemia and Sickle cell
anemia are the most prevalent genetic blood diseases in
Kuwait [62,63]. Furthermore, it is known that β-thalassemia
is the most common hereditary disease in Iran [64]; the ori-
gin of the individual sequenced in this study traces back to
the Fars province of Iran.
It is further assessed that the family of the individual
sequenced in this study has a history of migraine. Inconcordance with this medical history, we find that
the genome of the individual harbors 76 (out of 169)
variants that are associated with migraine in GWAS
Catalog.
The identified variants include deleterious and loss-of-
function coding variants, as well as critical non-coding
variants that are associated with phenotype traits – some
of the notable phenotype traits include: decrease in birth
weight, protection towards Type 1 diabetes, decrease in
Thareja et al. BMC Genomics  (2015) 16:92 Page 10 of 14long term memory, greater triglyceride lowering ability
in response to fenofibrate treatment, and higher warfarin
doses to elicit anticoagulation response.
Conclusions
This is the first study to report a reference genome re-
source for the population of Persian ancestry. We report
novel genome variants that include SNPs, indels and
structural variations that enlarge the current repertoire
of human genome variation. Nearest-neighbor tree built
using shared disease-causing variants between the
Persian genome and other continental genome positions
the Persian genome between the Asian and European
genomes; this is in concordance with the geographical
location of the origin of the sample at the nexus of Asian
and European continent. Apart from the findings from
population-context, the study illustrates that the par-
ticipant’s medical history of Type 2 diabetes and β-
Thalassemia as well as the medical history of migraine
in the family of the participant, are accounted by the
presence of a large number of genome variants that are
known to be associated with these traits. The presented
genome data provides a starting point for designing
large-scale genetic studies in Persian population.
Methods
Ethics statement
The study was approved by the Scientific Advisory
Board and the Ethics Advisory Committee at Dasman
Diabetes Institute, Kuwait. Written informed consent for
the study was obtained from the participant before blood
samples were collected.
Sample collection and library preparation
Blood sample was collected in EDTA 4 ml tube. Gentra
Puregene® kit (Qiagen, Valencia, CA, USA) was used to
extract DNA as per manufacturer’s protocols. DNA was
quantified using both the Quant-iT™ PicoGreen® dsDNA
Assay Kit (Life Technologies, NY, USA) and the Epoch
Microplate Spectrophotometer.
Prior to library preparation, frozen DNA stock was di-
luted to a working solution of 50 ng/μl as recommended
by Illumina (CA, USA) and was quantified by agarose
gel analysis. DNA sample was sheared to generate uni-
form size segments averaging around 400 bps by using
Covaris E220 instrument (Covaris, Woburn, MA, USA)
with the parameters of Duty Cycle 10%; Intensity 4; Cy-
cles per Burst 200; and Time 55 seconds. Sheared DNA
was used to prepare sequencing libraries using TruSeq
DNA sample preparation and cBot Paired End (PE)
cluster generation kits as per manufacturer’s protocols
(Illumina, CA, USA). Libraries were loaded on a HiSeq
2000 flow cell for paired-end sequencing using the Tru-
Seq SBS 200 cycles chemistryImage analysis and alignment of reads from whole
genome sequencing
CASAVA v1.8.2 (Illumina Inc, USA) was used for demul-
tiplexing and Bcl to fastq conversion. The generated
paired-end reads were aligned to human reference gen-
ome hg19 using BWA v0.6.2 [65]; default parameters
were used with the exception of “–q 30” for aln com-
mand to allow trimming at the 3′ ends of the reads. The
resultant SAM files were converted to BAM using Se-
quence Alignment/Map (SAM) tools v0.1.18 [66], where
bit representing “each segment properly aligned accord-
ing to the aligner” is set in SAM bitwise FLAG. Align-
ments were visualized using GenomeBrowse™ v1.1 by
Golden Helix, Inc.
SNP and indel discovery
We used a modified HugeSeq [67] pipeline, which en-
ables the pipeline to run on multi-core Linux Desktops,
to standardize the variant discovery process. Quality
control checks on BAM files were performed before
variant calling using tools in Genome Analysis Toolkit
(GATK) v2.4-7-g5e89f01 [68] and Picard v1.86 toolkit as
recommended in HugeSeq pipeline. We observe
4,118,585 variants (SNPs + indels) using GATK Unified-
Genotyper [20] and 4,227,839 variants using SAMtools.
The consensus set between the two methods, as re-
ported in this work, includes 3,977,923 variants. The
consensus set, which was determined using vcftools isec
method [69], was used in all subsequent analyses.
Mitochondrial and Y-chromosome haplogroup analysis
The paired-end reads aligned to hg19 mitochondrial se-
quence were realigned to rCRS (Revised Cambridge Ref-
erence Sequence) [70] using all the quality control steps
that we adopted for calling variants. The variants were
used to call haplogroups using HaploGrep [71]. The data
conversion from VCF file to HaploGrep input file (.hsd
file) was performed manually. The Y-chromosome vari-
ants were used to call haplogroups using AMY-tree soft-
ware [72].
Annotation of variants
SNP & Variation Suite v8.1 (SVS) [Bozeman, MT:
Golden Helix, Inc] was used to annotate variants as
“known” or “novel” by considering dbSNP 138 database
as reference.; a variant is annotated as “novel”, if the
variant is not present in dbSNP or the alternate allele
seen in the genome is not a subset of those annotated in
dbSNP database. We further classified the variants ac-
cording to their genomic annotation into 10 categories
using the SVS tool. Exonic variants were further classi-
fied into 13 categories based on their location within the
genes and their effects on protein sequences. The nonsy-
nonymous variants were examined for damaging effects
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Phen2 [74] annotations. Variants that are annotated
either by SIFT as ‘Damaging’ OR by PolyPhen2 as ‘Prob-
ably Damaging’ are classified as “deleterious” [75]. The
NHGRI GWAS Catalog [76] was used to annotate SNPs
for association with human diseases and other pheno-
type traits using Annovar [77].
Detecting structural variations
We used four different algorithms as part of HugeSeq
pipeline, to detect structural variations from paired-end
reads. BreakDancer version 1.1 [78] uses anonymous
long or short span size between the paired-end reads to
identify long indels. Furthermore, it identifies both
intra- and inter-chromosomal translocations. Pindel ver-
sion0.2.4 [79] was used for split‐read analysis. CNVnator
version 0.2.7 [80] was used to perform read‐depth ana-
lysis. BreakSeq Lite version 1.0 [81] was used for junc-
tion mapping. Calls from the different tools were
merged, using BEDTools [82], if the reciprocator overlap
between two variants is ≥ 0.5. Deletions were annotated
using Annovar [77]. A detected structural variation is
defined to be ‘known’ if at least 50% of the detected
variation (e.g. deletion) overlaps with annotated varia-
tions (e.g. deletions) in the Database of Genomic Vari-
ants [46,83]; otherwise, the deletion is considered to be
“novel”. Repeat content of the identified structural varia-
tions are estimated using rmsk (RepeatMasker) tables
from UCSC [84].
Calculation of intergenome distances between the KWP1
genome and representative genomes from continental
populations
We consider a total of 10 genomes covering diverse
ethnicities (African, Asian, European, and American),
downloaded from the sites of 10Gen [85], for comparing
the intergenome similarities with the genome sequenced
in our study.
We adopted the methods developed by Moore et al.
[85] to calculate intergenome distances based on infor-
mation relating to shared variant locations between ge-
nomes. We constructed the nearest-neighbor tree that is
based on such calculated intergenome distances using
PHYLIP [86].
Similar method was used to construct phylogenetic
tree using 100 Qatari exomes [13] without bootstrap
analysis.
Depiction of consensus nearest-neighbor tree based
on shared variants among genomes with known
disease-causing/predisposing alleles as cataloged in
OMIM
The tree depicting OMIM phylogenetic comparison is
constructed with the method of Moore et al. (describedin the previous section) used to construct the nearest-
neighbor tree based on genome-wide shared variants,
but restricting the shared variant locations between ge-
nomes to include only those locations where at least one
of the genomes contain an OMIM [87] allele. The tree
was bootstrapped 50 times, and labels on the nodes de-
pict the resulting bootstraps.
Building the genome browser to visualize the sequenced
genome
Genome browser provides an effective means to share
genome data to biomedical community; we have set up
JBrowse (version 1.8.1), a graphical interface to enable
access to the reported whole genome sequences. JBrowse
is an open-source project for genome browser [88]. We
have facilitated visualization of external data (such as
genome variants reported in Database of Genomic Vari-
ant and dbSNP 138) along with the KWP1 genome.
Availability of supporting data
The reported whole genome sequence and all the identified
variants (known and novel) are available on the ftp site
(http://dgr.dasmaninstitute.org/DGR/downloads.html). The
data can be visualized using genome browser with other an-
notations tracks from UCSC at http://dgr.dasmaninstitute.
org/DGR/gb.html. Proper functionality of the web server
requires Firefox version 6 (or later versions) or Internet
Explorer version 10 (or later versions).
In addition, the data has been deposited with the
NCBI data repositories. The whole genome sequencing
reads are deposited with NCBI SRA (Sequence Read
Archive) (accession number: SRX535330), the SNPs and
indels with NCBI dbSNP (Database of short genetic vari-
ations), and the CNV/SV structural variation calls with
NCBI dbVar (Database of genomic structural variation)
(accession number: nstd99).
Additional files
Additional file 1: Figure S1. PCA depicting position of sequenced
sample in three Kuwaiti population subgroups.
Additional file 2: Figure S2. Nearest-neighbor tree based on variant
positions shared between the KWP1 samples and 100 exomes from
Qatar. QA: Qatari Exomes of Sub-Saharan African Ancestry; QB: Qatari
Exomes of Bedouin Ancestry; QP: Qatari Exomes of Persian Ancestry.
Additional file 3: Figure S3. Chromosomal distribution of mean Ti/Tv
ratio for known and novel markers.
Additional file 4: Table S1. Classification of the identified SNPs based
on genome annotation. SNP & Variation Suite v8.1 (SVS) [Bozeman, MT:
Golden Helix, Inc] was used to annotate variants.
Additional file 5: Table S2. List of the 61 identified exonic LOF (Loss of
Function) SNPs that are homozygous alternate. These SNPs lead to
premature stops and splice-site disruptions resulting in complete loss of
function.
Additional file 6: Table S3. List of the 69 identified exonic LOF (Loss of
Function) indels that are homozygous alternate. These indels lead to
Thareja et al. BMC Genomics  (2015) 16:92 Page 12 of 14premature stops, splice-site disruptions and frameshifts resulting in
complete loss of function.
Additional file 7: Figure S4. Allele frequency analyses of the identified
homozygous exonic Loss-of-Function SNPs. Allele frequencies were
obtained using data from the 1000 Genomes Project.
Additional file 8: Table S4. List of 17 LOF SNPs annotated as
expression quantitative trait loci (eQTLs) in various populations. This list of
17 SNPs is a subset of the 61 LOF homozygous alternate SNPs presented
in Additional file 5: Table S2.
Additional file 9: Table S5. List of the 2,123 ‘known’ deleterious SNPs
identified in the Persian genome sequenced in this study. Variants that
are annotated either by SIFT as ‘Damaging’ OR by PolyPhen2 as ‘Probably
Damaging’ are classified as “deleterious”.
Additional file 10: Table S6. List of the 91 ‘novel’ deleterious SNPs
identified in the Persian genome sequenced in this study. Variants that
are annotated either by SIFT as ‘Damaging’ OR by PolyPhen2 as ‘Probably
Damaging’ are classified as “deleterious”.
Additional file 11: Table S7. Genotype-phenotype associations
(as annotated in NHGRI GWAS Catalog) in the case of 6,328 ‘known’
non-coding SNPs identified in the Persian genome sequenced in this
study. These SNPs are associated with 811 traits.
Additional file 12: Table S8. Genome wide association studies
annotating the 72 Type 2 Diabetes (T2D) SNPs identified in the Persian
genome sequenced in this study. This list of 72 T2D SNPs is a subset of
159 T2D SNPs annotated in NHGRI GWAS Catalog.
Additional file 13: Table S9. Read depth in genome regions
containing heterozygous SNPs with genotype calls that are discordant
between sequencing and bead chip data. On examining 97 such
heterozygous SNPs, the read depth in these regions ranges from 2–35
with a mean depth of 14.
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